1. Home
  2. SHPH vs BJDX Comparison

SHPH vs BJDX Comparison

Compare SHPH & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • BJDX
  • Stock Information
  • Founded
  • SHPH 2012
  • BJDX 2015
  • Country
  • SHPH United States
  • BJDX United States
  • Employees
  • SHPH N/A
  • BJDX N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • BJDX Medical Specialities
  • Sector
  • SHPH Health Care
  • BJDX Health Care
  • Exchange
  • SHPH Nasdaq
  • BJDX Nasdaq
  • Market Cap
  • SHPH 2.3M
  • BJDX 2.2M
  • IPO Year
  • SHPH 2022
  • BJDX 2021
  • Fundamental
  • Price
  • SHPH $3.58
  • BJDX $1.58
  • Analyst Decision
  • SHPH
  • BJDX
  • Analyst Count
  • SHPH 0
  • BJDX 0
  • Target Price
  • SHPH N/A
  • BJDX N/A
  • AVG Volume (30 Days)
  • SHPH 26.8K
  • BJDX 149.6K
  • Earning Date
  • SHPH 08-13-2025
  • BJDX 11-06-2025
  • Dividend Yield
  • SHPH N/A
  • BJDX N/A
  • EPS Growth
  • SHPH N/A
  • BJDX N/A
  • EPS
  • SHPH N/A
  • BJDX N/A
  • Revenue
  • SHPH N/A
  • BJDX N/A
  • Revenue This Year
  • SHPH N/A
  • BJDX N/A
  • Revenue Next Year
  • SHPH N/A
  • BJDX $55.56
  • P/E Ratio
  • SHPH N/A
  • BJDX N/A
  • Revenue Growth
  • SHPH N/A
  • BJDX N/A
  • 52 Week Low
  • SHPH $3.00
  • BJDX $1.26
  • 52 Week High
  • SHPH $56.25
  • BJDX $12.45
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 53.68
  • BJDX 59.67
  • Support Level
  • SHPH $3.34
  • BJDX $1.40
  • Resistance Level
  • SHPH $3.67
  • BJDX $1.51
  • Average True Range (ATR)
  • SHPH 0.20
  • BJDX 0.08
  • MACD
  • SHPH 0.04
  • BJDX 0.02
  • Stochastic Oscillator
  • SHPH 80.58
  • BJDX 79.58

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Share on Social Networks: